Multiple endocrine neoplasia: genes and variants
Explore variant evidence for Multiple endocrine neoplasia across 3 analyzed proteins (MEN1, RET, CDKN1B). Linked ClinVar records include 164 pathogenic or likely pathogenic variants, 2,474 variants of uncertain significance and 487 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Multiple endocrine neoplasia
MEN1: Menin
Its menin scaffold coordinates transcriptional and chromatin-regulatory complexes that restrain endocrine-cell proliferation. Germline loss-of-function variants cause multiple endocrine neoplasia type 1 with high risk of parathyroid, pituitary, and pancreatic neuroendocrine tumors.
111 ClinVar pathogenic / likely pathogenic and 884 uncertain variants in MEN1 have source records linked to Multiple endocrine neoplasia. Association strength is not clinical gene validity.
RET: Proto-oncogene tyrosine-protein kinase receptor Ret
Its activation by GDNF-family ligands guides development of the enteric nervous system, kidney, and other tissues. Activating variants cause multiple endocrine neoplasia type 2 and can drive cancer, whereas loss-of-function variants are an important cause of Hirschsprung disease.
53 ClinVar pathogenic / likely pathogenic and 1,669 uncertain variants in RET have source records linked to Multiple endocrine neoplasia. Association strength is not clinical gene validity.
CDKN1B: Cyclin-dependent kinase inhibitor 1B
It restrains cell-cycle progression by inhibiting cyclin-CDK complexes and integrates mitogenic and antiproliferative signals. Germline loss-of-function variants cause MEN4, while reduced expression or mislocalization is common in cancer.
0 ClinVar pathogenic / likely pathogenic and 407 uncertain variants in CDKN1B have source records linked to Multiple endocrine neoplasia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ALK and ATM.
ClinVar pathogenic and likely pathogenic variants linked to Multiple endocrine neoplasia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MEN1 E45D | 45 | Pathogenic / likely pathogenic (★★) | |
| MEN1 A164D | 164 | Pathogenic / likely pathogenic (★★) | |
| MEN1 C241R | 241 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 R452P | 452 | Pathogenic / likely pathogenic (★★) | |
| MEN1 M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| MEN1 M1K | 1 | Pathogenic / likely pathogenic (★★) | |
| MEN1 D33Y | 33 | Pathogenic / likely pathogenic (★★) | |
| MEN1 E45G | 45 | Pathogenic / likely pathogenic (★★) | |
| MEN1 E45K | 45 | Pathogenic / likely pathogenic (★★) | |
| MEN1 E45Q | 45 | Pathogenic / likely pathogenic (★★) | |
| MEN1 H139D | 139 | Pathogenic / likely pathogenic (★★) | |
| MEN1 H139Q | 139 | Pathogenic / likely pathogenic (★★) | |
| MEN1 H139R | 139 | Pathogenic / likely pathogenic (★★) | |
| MEN1 D153V | 153 | Pathogenic / likely pathogenic (★★) | |
| MEN1 G156C | 156 | Pathogenic / likely pathogenic (★★) | |
| MEN1 G156R | 156 | Pathogenic / likely pathogenic (★★) | |
| MEN1 G156D | 156 | Pathogenic / likely pathogenic (★★) | |
| MEN1 A164V | 164 | Pathogenic / likely pathogenic (★★) | |
| MEN1 C165Y | 165 | Pathogenic / likely pathogenic (★★) | |
| MEN1 L223P | 223 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 C241Y | 241 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 L256F | 256 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 M278R | 278 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 M278I | 278 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 P320L | 320 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 A337D | 337 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 D418H | 418 | Pathogenic / likely pathogenic (★★) | |
| MEN1 D418N | 418 | Pathogenic / likely pathogenic (★★) | |
| MEN1 D418Y | 418 | Pathogenic / likely pathogenic (★★) | |
| RET C609Y | 609 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C618G | 618 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C620R | 620 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C634Y | 634 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C634F | 634 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C634R | 634 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET M918V | 918 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| MEN1 L168P | 168 | Pathogenic / likely pathogenic (★★) | |
| MEN1 D172Y | 172 | Pathogenic / likely pathogenic (★★) | |
| MEN1 H181R | 181 | Pathogenic / likely pathogenic (★★) | |
| MEN1 G190R | 190 | Pathogenic / likely pathogenic (★★) | |
| MEN1 R275K | 275 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 H317Y | 317 | Interaction with FANCD2 | Pathogenic / likely pathogenic (★★) |
| MEN1 C421Y | 421 | Pathogenic / likely pathogenic (★★) | |
| RET C515S | 515 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C515Y | 515 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C515F | 515 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C609S | 609 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C609R | 609 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C611S | 611 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C618R | 618 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C618S | 618 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C620Y | 620 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C620S | 620 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C620W | 620 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C620F | 620 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C634S | 634 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C634L | 634 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET C634W | 634 | Extracellular | Pathogenic / likely pathogenic (★★) |
| RET M918T | 918 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| MEN1 M1V | 1 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 164.
Uncertain variants prioritized for review in Multiple endocrine neoplasia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| MEN1 G156S | 156 | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; G156C at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.972 | |
| MEN1 A176T | 176 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; A176P at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.943 | |
| MEN1 S253L | 253 | Interaction with FANCD2 | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; S253W at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.913 |
| MEN1 D315Y | 315 | Interaction with FANCD2 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; D315V at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.875 |
| MEN1 R452Q | 452 | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; R452G at the same position is pathogenic; seen in 3.5e-06 of gnomAD DNA copies; REVEL 0.932 | |
| MEN1 A164S | 164 | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; A164V at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.852 | |
| MEN1 Q141R | 141 | Conflicting reports (★) | +7: 9 other pathogenic changes within 3 positions; Q141L at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.968 | |
| MEN1 P320S | 320 | Interaction with FANCD2 | Uncertain (★★) | +7: 3 other pathogenic changes within 3 positions; P320L at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.973 |
| MEN1 R52C | 52 | Uncertain (★★) | +7: in a 3D region that tolerates change poorly (1R); R52G at the same position is pathogenic; seen in 7e-07 of gnomAD DNA copies; REVEL 0.905 | |
| MEN1 A342V | 342 | Interaction with FANCD2 | Uncertain (★★) | +7: 3 other pathogenic changes within 3 positions; A342P at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.865 |
| MEN1 R275G | 275 | Interaction with FANCD2 | Uncertain (★★) | +7: 5 other pathogenic changes within 3 positions; R275K at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.906 |
| MEN1 M278V | 278 | Interaction with FANCD2 | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; M278R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.929 |
| MEN1 L143V | 143 | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; L143R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.870 | |
| MEN1 R52S | 52 | Uncertain (★) | +7: in a 3D region that tolerates change poorly (1R); R52G at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.808 | |
| MEN1 R52H | 52 | Uncertain (★★) | +7: in a 3D region that tolerates change poorly (1R); R52G at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.866 | |
| MEN1 F144L | 144 | Uncertain (★) | +7: 4 other pathogenic changes within 3 positions; F144C at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.883 | |
| MEN1 P320R | 320 | Interaction with FANCD2 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; P320L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| MEN1 E179D | 179 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; E179K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| MEN1 L273P | 273 | Interaction with FANCD2 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; L273R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| MEN1 G42S | 42 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G42A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| MEN1 P32S | 32 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; P32R at the same position is pathogenic; REVEL 0.848 | |
| MEN1 A176S | 176 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A176P at the same position is pathogenic; REVEL 0.868 | |
| MEN1 H46Y | 46 | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; H46P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.93 | |
| MEN1 T344M | 344 | Interaction with FANCD2 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; T344R at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.733 |
| MEN1 F144V | 144 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; F144C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 | |
| MEN1 G419S | 419 | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; G419V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 | |
| MEN1 D172H | 172 | Uncertain (★) | +6: in a 3D region that tolerates change poorly (1R); D172Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| MEN1 P320A | 320 | Interaction with FANCD2 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; P320L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| MEN1 P277L | 277 | Interaction with FANCD2 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; P277H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| MEN1 P32L | 32 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; P32R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 | |
| MEN1 L22P | 22 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; L22M at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| MEN1 Y353S | 353 | Interaction with FANCD2 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; Y353D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| MEN1 G190E | 190 | Uncertain (★) | +6: in a 3D region that tolerates change poorly (1R); G190R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 | |
| RET M918I | 918 | Protein kinase | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; M918V at the same position is pathogenic; REVEL 0.898 |
| MEN1 C241G | 241 | Interaction with FANCD2 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; C241Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.81 |
| MEN1 L168V | 168 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; L168P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.85 | |
| MEN1 L143P | 143 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; L143R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| MEN1 D315H | 315 | Interaction with FANCD2 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; D315V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 |
| MEN1 L221V | 221 | Interaction with FANCD2 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; L221P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| MEN1 D418E | 418 | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; D418H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for Multiple endocrine neoplasia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 96 out of 100
- EVE: 95 out of 100
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 89 out of 100
- SIFT: 88 out of 100
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 85 out of 100
- phyloP: 79 out of 100
- SpliceAI: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Hirschsprung disease also has ClinVar records linked to RET variants; they fall mostly in different places as the Multiple endocrine neoplasia variants (22 pathogenic / likely pathogenic).
Diseases related to Multiple endocrine neoplasia
- Gastrointestinal stromal tumor, also linked to RET
- Pheochromocytoma, also linked to RET
- Ovarian cancer, also linked to RET
- Hirschsprung disease, also linked to RET
- Colorectal cancer, also linked to RET
- Non-small cell lung carcinoma, also linked to RET
- Familial medullary thyroid carcinoma, also linked to RET
- Hepatocellular carcinoma, also linked to RET
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia, also linked to RET
- MEN2 phenotype: Unclassified, also linked to RET
- Renal cell carcinoma, also linked to RET
- Medullary thyroid carcinoma, also linked to RET
Frequently asked questions
Which genes have records linked to Multiple endocrine neoplasia?
This view contains 3 analyzed proteins: MEN1, RET, CDKN1B. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 164 pathogenic or likely pathogenic variants, 2,474 variants of uncertain significance and 487 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 45 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 3,194 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center